The Swedish company continues to expand and at the end of February Peter Liss was appointed as Chief Financial Officer (CFO).
Peter Liss will be responsible for business development and he has several years of experience as CFO. Most recently he was CEO and CFO at Valneva Sweden and he has also had similar positions within other industries, for example Anoto, Kinnevik, IBM and Toolex.
“We are very excited that Peter will become part of Scandinavian Biopharma. He has experience of senior positions within our industry and he is a valuable addition to our growing company,” says Björn Sjöstrand CEO of Scandinavian Biopharma in the company press release.
“Scandinavian Biopharma is a very exciting and fast growing company. To be able to be a part of its journey and drive both the development of a new vaccine and further advance the company’s distribution organization feels great. That combination is unique,” says Peter Liss in the same press release.